Humalog and Minitran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Humalog (insulin lispro recombinant) and Minitran (nitroglycerin). Common drug interactions include bradycardia among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Humalog and Minitran. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Humalog?

Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.

What is Minitran?

Minitran has active ingredients of nitroglycerin. eHealthMe is studying from 950 Minitran users. Check the latest studies of Minitran.

On Jul, 15, 2026

31 people who take Humalog and Minitran together, and have interactions are studied.

What are the common drug interactions of Humalog and Minitran, by gender? *:

female:

Bradycardia (abnormally slow heart action)
Blood creatinine increased
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Hypercalcaemia (elevated calcium (ca+) level in the blood)

male:

Asthenia (weakness)
Bradycardia (abnormally slow heart action)
Blood urea increased
Blood cholesterol increased
Blood glucose increased
Blood pressure inadequately controlled
Blood triglycerides increased
Disease recurrence
Dyspnoea (difficult or laboured respiration)
Fluid retention (an abnormal accumulation of fluid in the blood)

What are the common drug interactions of Humalog and Minitran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Nail discolouration (change in nail colour)
Nail disorder (disease of nail)
Peripheral neuropathy (damage to nerves of the peripheral nervous system)

60+:

Bradycardia (abnormally slow heart action)
Asthenia (weakness)
Blood urea increased
Blood pressure inadequately controlled
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Disease recurrence
Dyspnoea (difficult or laboured respiration)
Fluid retention (an abnormal accumulation of fluid in the blood)
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Hypophagia (reduced food intake)

What are the existing conditions these people have? *

High Blood Pressure: 5 people, 16.13%
Type 2 Diabetes: 2 people, 6.45%
Osteoporosis (bones weak and more likely to break): 2 people, 6.45%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Humalog and Minitran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously